Zoetis Contract manufacturing & human health — Revenue decreased by 23.3% to $23.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.7%, from $29.00M to $23.00M. Over 4 years (FY 2021 to FY 2025), Contract manufacturing & human health — Revenue shows an upward trend with a 9.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful monetization of manufacturing assets or growth in the human diagnostics market, while a decrease may indicate reduced external demand or a strategic shift toward core animal health focus.
This metric represents the total revenue generated from contract manufacturing services provided to third parties and th...
Peers in the life sciences or pharmaceutical sector often report similar 'other revenue' or 'contract services' segments, which are typically evaluated based on their contribution margin relative to core business lines.
zts_segment_contract_manufacturing_human_health_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.50M | $20.50M | $20.50M | $21.50M | $21.50M | $21.50M | $21.50M | $19.50M | $19.50M | $19.50M | $19.50M | $20.00M | $18.00M | $21.00M | $21.00M | $29.00M | $34.00M | $23.00M | $30.00M | $23.00M |
| QoQ Change | — | +0.0% | +0.0% | +4.9% | +0.0% | +0.0% | +0.0% | -9.3% | +0.0% | +0.0% | +0.0% | +2.6% | -10.0% | +16.7% | +0.0% | +38.1% | +17.2% | -32.4% | +30.4% | -23.3% |
| YoY Change | — | — | — | — | +4.9% | +4.9% | +4.9% | -9.3% | -9.3% | -9.3% | -9.3% | +2.6% | -7.7% | +7.7% | +7.7% | +45.0% | +88.9% | +9.5% | +42.9% | -20.7% |